EGLN1 antibody (N-Term)
Quick Overview for EGLN1 antibody (N-Term) (ABIN2888337)
Target
See all EGLN1 AntibodiesReactivity
Host
Clonality
Conjugate
Application
-
-
Binding Specificity
- N-Term
-
Specificity
- Specific for human HIF prolyl hydroxylase 2. Species cross-reactivity: Human. This antibody does not appear to work in mouse. Results have been mixed in rat with success in western analysis and immunofluorescence on rat endothelial cells
-
Purification
- Immunoaffinity purified
-
Immunogen
-
A synthetic peptide made to an N-terminal sequence of the human EGL9 homolog 1 (between residues 1-50). [LocusLink ID 54583].
Type of Immunogen: Synthetic peptide
-
-
-
-
Application Notes
-
Approved: IHC, WB
Usage: Suitable for use in Western Blot and Immunohistochemistry. -
Comment
-
Target Species of Antibody: Human
-
Restrictions
- For Research Use only
-
-
-
Concentration
- Lot specific
-
Storage
- 4 °C,-20 °C
-
Storage Comment
-
Short term: 4°C
Long term: Add glycerol (40-50%) -20°C.
-
-
- EGLN1 (Egl-9 Family Hypoxia Inducible Factor 1 (EGLN1))
-
Alternative Name
- EGLN1 / PHD2
-
Background
-
Name/Gene ID: EGLN1
Synonyms: EGLN1, C1orf12, EGL9, ECYT3, Egl nine-like protein 1, HIFPH2, HIF prolyl hydroxylase 2, HIF-PH2, HIF-prolyl hydroxylase 2, ZMYND6, PHD2, SM20, EGL nine (C.elegans) homolog 1, Egl nine homolog 1, HPH-2, HPH2, SM-20 -
Gene ID
- 54583
-
UniProt
- Q9GZT9
-
Pathways
- cAMP Metabolic Process, Warburg Effect
Target
-